136 related articles for article (PubMed ID: 33115916)
1. Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic Study.
Hsu S; Zelnick LR; Lin YS; Best CM; Kestenbaum B; Thummel KE; Rose LM; Hoofnagle AN; de Boer IH
J Am Soc Nephrol; 2021 Jan; 32(1):188-198. PubMed ID: 33115916
[TBL] [Abstract][Full Text] [Related]
2. Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials.
de Boer IH; Sachs MC; Chonchol M; Himmelfarb J; Hoofnagle AN; Ix JH; Kremsdorf RA; Lin YS; Mehrotra R; Robinson-Cohen C; Siscovick DS; Steffes MW; Thummel KE; Tracy RP; Wang Z; Kestenbaum B
Am J Kidney Dis; 2014 Aug; 64(2):187-97. PubMed ID: 24703961
[TBL] [Abstract][Full Text] [Related]
3. Validation of the 24,25-dihydroxyvitamin D
Hsu S; Zelnick LR; Lin YS; Best CM; Kestenbaum BR; Thummel KE; Hoofnagle AN; de Boer IH
J Steroid Biochem Mol Biol; 2022 Mar; 217():106047. PubMed ID: 34954017
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D Status in Chronic Kidney Disease - UVB Irradiation Is Superior to Oral Supplementation.
Krause R; Roth HJ; Kaase H; Stange R; Holick MF
Anticancer Res; 2016 Mar; 36(3):1397-401. PubMed ID: 26977042
[TBL] [Abstract][Full Text] [Related]
5. Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD.
Stubbs JR; Zhang S; Friedman PA; Nolin TD
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1965-73. PubMed ID: 25183657
[TBL] [Abstract][Full Text] [Related]
6. National Estimates of Serum Total 25-Hydroxyvitamin D and Metabolite Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry in the US Population during 2007-2010.
Schleicher RL; Sternberg MR; Looker AC; Yetley EA; Lacher DA; Sempos CT; Taylor CL; Durazo-Arvizu RA; Maw KL; Chaudhary-Webb M; Johnson CL; Pfeiffer CM
J Nutr; 2016 May; 146(5):1051-61. PubMed ID: 27052537
[TBL] [Abstract][Full Text] [Related]
7. Racial differences in markers of mineral metabolism in advanced chronic kidney disease.
Jovanovich A; Chonchol M; Cheung AK; Kaufman JS; Greene T; Roberts WL; Smits G; Kendrick J;
Clin J Am Soc Nephrol; 2012 Apr; 7(4):640-7. PubMed ID: 22383748
[TBL] [Abstract][Full Text] [Related]
8. Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3.
Halloran BP; Schaefer P; Lifschitz M; Levens M; Goldsmith RS
J Clin Endocrinol Metab; 1984 Dec; 59(6):1063-9. PubMed ID: 6333430
[TBL] [Abstract][Full Text] [Related]
9. Effects of Vitamin D
Batacchi Z; Robinson-Cohen C; Hoofnagle AN; Isakova T; Kestenbaum B; Martin KJ; Wolf MS; de Boer IH
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1498-1506. PubMed ID: 28768705
[TBL] [Abstract][Full Text] [Related]
10. Modifiers of Plasma 25-Hydroxyvitamin D and Chronic Kidney Disease Outcomes in Black Americans: The Jackson Heart Study.
Lunyera J; Davenport CA; Pendergast J; Musani SK; Bhavsar NA; Sims M; Mwasongwe S; Wolf M; Diamantidis CJ; Boulware LE; Scialla JJ
J Clin Endocrinol Metab; 2019 Jun; 104(6):2267-2276. PubMed ID: 30668751
[TBL] [Abstract][Full Text] [Related]
11. The plasma free fraction of 25-hydroxyvitamin D
Best CM; Thummel KE; Hsu S; Lin Y; Zelnick LR; Kestenbaum B; Kushnir MM; de Boer IH; Hoofnagle AN
J Steroid Biochem Mol Biol; 2023 Feb; 226():106206. PubMed ID: 36404469
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.
Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH;
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935
[TBL] [Abstract][Full Text] [Related]
14. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
Vaes AMM; Tieland M; de Regt MF; Wittwer J; van Loon LJC; de Groot LCPGM
Clin Nutr; 2018 Jun; 37(3):808-814. PubMed ID: 28433267
[TBL] [Abstract][Full Text] [Related]
15. The effect of some medications given to CKD patients on vitamin D levels.
Yuste C; Quiroga B; de Vinuesa SG; Goicoechea MA; Barraca D; Verdalles U; Luño J
Nefrologia; 2015; 35(2):150-6. PubMed ID: 26300508
[TBL] [Abstract][Full Text] [Related]
16. Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study.
Mariani LH; White MT; Shults J; Anderson CA; Feldman HI; Wolf M; Reese PP; Denburg MR; Townsend RR; Lo JC; Cappola AR; Carlow D; Gadegbeku CA; Steigerwalt S; Leonard MB;
J Ren Nutr; 2014 May; 24(3):186-93. PubMed ID: 24613295
[TBL] [Abstract][Full Text] [Related]
17. The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease.
Bosworth CR; Levin G; Robinson-Cohen C; Hoofnagle AN; Ruzinski J; Young B; Schwartz SM; Himmelfarb J; Kestenbaum B; de Boer IH
Kidney Int; 2012 Sep; 82(6):693-700. PubMed ID: 22648296
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.
Levin A; Bakris GL; Molitch M; Smulders M; Tian J; Williams LA; Andress DL
Kidney Int; 2007 Jan; 71(1):31-8. PubMed ID: 17091124
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biomarker modifiers of vitamin D treatment response: the Multi-Ethnic Study of Atherosclerosis.
Hsu S; Prince DK; Williams K; Allen NB; Burke GL; Hoofnagle AN; Li X; Liu KJ; McClelland RL; Michos ED; Psaty BM; Shea SJ; Rice KM; Rotter JI; Siscovick D; Tracy RP; Watson KE; Kestenbaum BR; de Boer IH
Am J Clin Nutr; 2022 Mar; 115(3):914-924. PubMed ID: 34849546
[TBL] [Abstract][Full Text] [Related]
20. Race-specific associations of 25-hydroxyvitamin D and parathyroid hormone with cardiometabolic biomarkers among US white and black postmenopausal women.
Xia J; Tu W; Manson JE; Nan H; Shadyab AH; Bea JW; Cheng TD; Hou L; Song Y
Am J Clin Nutr; 2020 Aug; 112(2):257-267. PubMed ID: 32469401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
